Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions
A very interesting read, shared by our BEAMER colleagues at Pfizer. It identifies not only risk factors for adherence in three disease areas, but also the potentially most effective interventions to improve adherence. The conclusions of this...Read more
Over a year of hard work from the BEAMER team and the first deliverables are a fact.
Aad Liefveld shared the deliverables for Work Package 1, where the team analyzed the available literature to establish a solid background on the behavioral model that will be used.
32 theoretical behavioral models have been identified and analyzed in different areas like actionability and patient...Read more
Again a very motivated group of Research Nurses becoming experts in their field. Simon Klaasen is happy to contribute with our knowledge of patient recruitment strategies. Breederode University of Applied Sciences Rotterdam provides a 1-year specific training course for research nurses/clinical trial coordinators to become experts in the field of setting up and supporting clinical...Read more
My name is Stephanie Maria Gontijo dos Santos Lima and I want to share a bit about my journey in the last 4 years with Link2Trials.During the last years of my medical studies, I worked as a PSL for different clinical trials in different countries: from Spain, UK to USA and for studies recruiting people with conditions such as back pain, to diabetes or cancer. Working with recruiting...Read more
An interesting discussion about DCT
An interesting discussion about DCT, started by Moe Alsumidaie.As a service provider we have supported a number of DCT’s. Some designs worked out fine for patients and sites, others not so much. From what we have seen so far, the successful ones were not technology or decentralization driven but made sensible choices about what could easily be...Read more
A must-read for anyone who wants to understand what impact tailored behavioral interventions can have on adherence!
This is precisely why we have developed our adherence support services for clinical studies. Thank you for sharing your insights, Dr Katerina Kassavou, Chimweta Chilala and Professor Stephen Sutton of the University of Cambridge.
At Link2Trials we are excited to be part of this latest initiative to develop a model to predict adherence behavior.
This model will help healthcare providers to better support patients and enable the pharma industry to develop better products and services.
What a great BEAMER team we have! So many wonderful, interesting and foremost focused and motivated people!...Read more
Link2Trials uses its PSL to ensure the potential trial participants we refer match the study in- and exclusion criteria.
Claire speaking:I’ve recently started working in a Patient Site Liaison (PSL) research role with Link2Trials. The role requires contacting patients who have expressed an interest online for participating in research studies relevant to themselves. I was attracted to the...Read more
Did you miss the webonar about how partnerschips can streamline your next clinical trial from Xtalks?
Or did you join the live webinar but want to review the presentation, click below to watch the recording.
In this webinar Simon Klaasen, Sandra Tobisch and Derk Arts, discussed:
The importance of interoperability to reduce site and patient burden
Considerations for...Read more
Did you miss last week's BEAMER webinar?
Kicking off our BEAMER webinar series this month, we explore the scope of non-adherence with expert panelists from across the EU.BEAMERBEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe
Click below and watch...Read more
Looking for a seamless experience for patients within your decentralized clinical trial?Because of their patient-centric approach DCTs will address important patient needs that often go unmet in a traditional, site-based set-up. By nature DCTs make clinical trial participation less burdensome, enable a more representative patient access, help develop a stronger evidence package and...Read more
Breederode University of Applied Sciences Rotterdam provides a 1-year specific training course for research nurses/clinical trial coordinators to become experts in the field of setting up and supporting clinical trials.
Great to see that this course has a specific focus on patient recruitment. This afternoon Simon Klaasen will give a guest lecture and share his expertise in the field of patient...Read more
Partnerships are a key to success when it comes time for your company’s next clinical trial. In this blog post, we will illustrate how building an effective partnership ecosystem can speed up timelines while optimizing operational activities in a clinical trial while highlighting a recent success story between Essity, Link2Trials, and Castor.
How to integrate partnerships to...Read more
"Really fantastic feeling to have finalized enrolment of the 150 patients in our placebo-controlled study in bacterial vaginosis #Nefertiti - What an achievement by the Gedea Biotech AB team, the sites, LINK Medical Research, Link2Trials - and what a milestone for us!"
Read the full press release on the Gedea Biotech AB website: Link
PRESS RELEASE: clinical study for our lead...Read more
Decentralized trials are here to stay!
Not just for a pandemic: Decentralized trials "are here to stay, and they should be deployed in a fit-for-purpose manner"
Decentralized clinical trials are here to stay, and the long-term benefits outweigh the higher initial costs and technical challenges of remote...Read more
Link2Trials uses its PSLs to ensure the potential trial participants we refer fit the study in and exclusion criteria.
My name is Tamara. I have been working as a Patient Site Liaison (PSL) at LinkTrials for several years now. As a PSL you are the link between a large number of applications and the actual (potential) participants for a clinical study. With a medically relevant background,...Read more
It doesn't get more patient centric than this!BEAMER the latest EFPIA - European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative (IMI) initiative is about finding a new and effective way to improve patient adherence to treatment.
BEAMER will focus on assessing and understanding patient needs. At Link2Trials we are honored to be part...Read more
When discussing patient adherence during clinical trials, most people will say that on average it is high and that the issue of non-adherence really surfaces during clinical care. But is this true or are we missing something in clinical trials? I think we are missing something, and the issue is far greater than we think it is.
Early drop-out during clinical trials has always been and still is an...Read more
In the past few months the healthcare industry has sped up the adoption and implementation of digital remote healthcare solutions to meet patients’ health-related preferences and at the same time overcome the challenges of social distancing and limited human interaction. The pharmaceutical industry is also moving forward on the subject of virtual and hybrid clinical trials.
The many...Read more
Join Link2Trials and EFPIA-IMI to improve patient adherence!
It is official now! A few weeks ago we have received confirmation from the EFPIA Innovative Medicine Initiative (IMI) that Link2Trials has been accepted as Associated Partner for the patient adherence improvement project (Call 23, Topic 6).
Patient non-adherence to prescribed treatment is an issue that affects patient health outcomes...Read more
In most countries, regular care will be one of the first things to re-start post-Covid-19. With that, some of our clinical trials can re-start as well. We have discussed the re-start of trial recruitment with a lot of sites for a lot of studies in different countries and indications. This resulted in 4 pointers, for you to ensure the re-start of your trials and trial recruitment is as smooth as...Read more
Today early drop-out still is a major challenge we must deal with when running clinical trials. The past few years patient centricity and patient engagement initiatives have generated major improvements. This is the second in a series of articles about a different perspective on the subject and a new and innovative approach to improve early drop-out rates.
Communicating information...Read more
Today early drop-out still is a major challenge we must deal with when running clinical trials. The past few years patient centricity and patient engagement initiatives have generated major improvements. This is the first in a series of articles about a different perspective on the subject and a new and innovative approach to improve early drop-out rates.
Early Drop-out; still a major...Read more
A plea to express gratitude
Recently, I shared an editorial article from Nature on LinkedIn about the value and importance of true patient engagement in clinical trials. Involving patients from the earliest start of the clinical trial can and will lead to more effective and feasible clinical trial protocols. Patients are equivalent partners, and researchers need to incorporate patient feedback...Read more